Adenocarcinoma of the Pancreas Withdrawn Phase 2 Trials for Erlotinib (DB00530)

Also known as: Pancreatic adenocarcinoma / Adenocarcinoma Pancreas / Pancreas, Adenocarcinoma / Pancreas Adenocarcinoma / Adenocarcinoma of Pancreas / Adenocarcinoma, Pancreas

IndicationStatusPhase
DBCOND0029532 (Adenocarcinoma of the Pancreas)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00728000Phase II Study Of Neoadjuvant Chemotherapy In Borderline Resectable Pancreatic AdenocarcinomaTreatment